Please provide your email address to receive an email when new articles are posted on . Safety and efficacy of aspirin did not differ for men vs. women with atherosclerotic heart disease. Women ...

No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). No ...

Research presented at the 2024 European Society of Cardiology Congress explored gender-based care and outcomes disparities, with potential implications for health care policy and equitable care of ...

In noncardioembolic cerebrovascular disease (CVD), the use of antiplatelet agents rather than anticoagulants is recommended to reduce the risk of recurrent stroke and other cardiovascular events ...